Europe

Christian Meyer and Gisela Grabow of Maiwald explore proposed changes to new EU provisions aimed at facilitating faster market entry for generics and biosimilars, so as to allegedly bolster competition and enhance patient access

Uğur Aktekin and Begüm Soydan Sayılkan of Gün + Partners highlight several decisions concerning the Turkish Patent and Trademark Office’s well-known trademark registry and say clarification of its standing is eagerly awaited

Christian Meyer and Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended protection for medicinal products through a unitary supplementary protection certificate

Katharina Pehle of Bird & Bird considers the legislative progress and potential impact of a regulation on standard-essential patents as the proposal continues to draw criticism, despite approval by the European Parliament

An EPO board of appeal decision has challenged the office’s standing in requiring applicants to adapt the description text of patent applications to be in accordance with amended claims, says Edward Farrington of Inspicos

Christian Meyer and Gisela Grabow of Maiwald discuss potential changes to the EU pharmaceutical regulation and their potential impact on data and market protection timelines for medicinal products